Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Equity Average (2016 - 2025)

Sanara MedTech's Equity Average history spans 12 years, with the latest figure at $6.0 million for Q4 2025.

  • For Q4 2025, Equity Average fell 84.6% year-over-year to $6.0 million; the TTM value through Dec 2025 reached $6.0 million, down 84.6%, while the annual FY2025 figure was $22.4 million, 46.3% down from the prior year.
  • Equity Average reached $6.0 million in Q4 2025 per SMTI's latest filing, down from $20.8 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $44.3 million in Q4 2023 to a low of $6.0 million in Q4 2025.
  • Average Equity Average over 5 years is $35.3 million, with a median of $38.5 million recorded in 2024.
  • Peak YoY movement for Equity Average: skyrocketed 509.11% in 2021, then plummeted 84.6% in 2025.
  • A 5-year view of Equity Average shows it stood at $31.8 million in 2021, then soared by 35.85% to $43.2 million in 2022, then rose by 2.68% to $44.3 million in 2023, then decreased by 11.64% to $39.2 million in 2024, then tumbled by 84.6% to $6.0 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Equity Average are $6.0 million (Q4 2025), $20.8 million (Q3 2025), and $36.0 million (Q2 2025).